A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats
- 1 January 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 63 (1), 134-142
- https://doi.org/10.1046/j.1523-1755.2003.00737.x
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonistBritish Journal of Pharmacology, 2001
- Complement and renal ischemia-reperfusion injuryAmerican Journal of Kidney Diseases, 2001
- Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridizationKidney International, 2001
- Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the ratKidney International, 2000
- Pharmacological characterization of antagonists of the C5a receptorBritish Journal of Pharmacology, 1999
- Intestinal ischemia-reperfusion injury is mediated by the membrane attack complexSurgery, 1999
- Effects of a new C5a receptor antagonist on C5a- and endotoxin- induced neutropenia in the ratBritish Journal of Pharmacology, 1999
- Inhibition of complement activity by humanized anti-C5 antibody and single-chain FvMolecular Immunology, 1996
- Role of endothelin in the pathophysiology of renal ischemia-reperfusion in normal rabbitsKidney International, 1996
- Antibodies to ICAM-1 Protect Kidneys in Severe Ischemic Reperfusion InjuryBiochemical and Biophysical Research Communications, 1995